COG8 Protein: A Potential Drug Target for Neurological Disorders

Target Name: COG8

NCBI ID: G84342

COG8

COG8 Protein: A Potential Drug Target for Neurological Disorders

COG8 (CDG2H), a protein located in the cell membrane of neurons, has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. Its function in neural communication and the regulation of synaptic plasticity have been extensively studied, and its role in the development and progression of neurodegenerative diseases has gained significant attention in recent years.

The COG8 protein is a member of the neurotransmitter-gated ion channel (Na+/K+-ATPase) family, which is involved in the regulation of neural signaling. It is expressed in high levels in the prefrontal cortex, a region of the brain that is responsible for executive functions and decision-making. The COG8 protein is known to play a crucial role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

Several studies have demonstrated that the COG8 protein is involved in the regulation of synaptic plasticity, including the modulation of the strength of synaptic connections and the modulation of neurotransmitter release. Its role in synaptic plasticity has been implicated in the development and progression of various neurological and Psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

In addition to its role in synaptic plasticity, the COG8 protein has also been shown to be involved in the regulation of neuronal excitability and the modulation of ion channels in the nervous system. Its role in these processes has been implicated in the development and progression of epilepsy, as well as the regulation of action potentials in neuronal cells.

The COG8 protein is also expressed in the immune system, which is involved in the regulation of inflammation and immune cell function. Its role in the immune system has been implicated in the development and progression of various autoimmune diseases, including multiple sclerosis and rheumatoid arthritis.

Given its involvement in the regulation of synaptic plasticity and its potential role in the development of various neurological and psychiatric disorders, the COG8 protein is an attractive drug target for researchers. Studies have shown that the COG8 protein can be modulated with small molecules, such as those that act on ion channels or neurotransmitter receptors. Additionally, the COG8 protein is a good candidate for a biomarker for various neurological disorders due to its robust expression and stability in the brain.

In conclusion, the COG8 protein is a potential drug target and biomarker for various neurological and psychiatric disorders. Its role in the regulation of synaptic plasticity and its involvement in the immune system make it an attractive target for researchers. Further studies are needed to fully understand its function and its potential as a drug or biomarker.

Protein Name: Component Of Oligomeric Golgi Complex 8

Functions: Required for normal Golgi function

The "COG8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COG8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets